- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request A Presentation
- ADPKD Simulator
- Patient Resources
- Log In
- Join
- Log Out
- Account
Archives
Discover The PKD Foundation’s ADPKD Centers Of Excellence Program
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Discover The PKD Foundation’s ADPKD Centers Of Excellence Program
Background
The PKD Foundation’s Centers of Excellence (COE) program is built upon the belief that the best way to provide ADPKD-centered care is through patient-focused, comprehensive care with the coordination and support of an integrated care team. The program’s mission stands on three pillars:- understanding Polycystic Kidney Disease (PKD) through research
- ensuring better care for all individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- educating and empowering the community.
Why Attend This Webinar?
- Take a deep dive into the PKD Foundation COE initiative to coordinate and standardize specialty care for patients with PKD, which includes the professional network created between Centers of Excellence and designated Partner Clinics across the United States.
- Be part of the PKD professional community that is empowering patients, advancing research, and optimizing care for those affected by PKD in hopes of improving outcomes.
- Receive information on how to apply to the program and hear from the PKD Foundation about the critical deadlines for the 2023 application cycle.
Featuring
Elise Hoover, MPH
Vice President of Research ProgramsPKD Foundation*
Elise is the Vice President of Research Programs at the PKD Foundation. She has led the design and implementation of the ADPKD Registry and Centers of Excellence in ADPKD programs along with members of the clinician, researcher, and patient communities. Before joining the PKD Foundation, Elise received her Bachelor of Arts from New York University and a Masters in Public Health degree from Boston University. After earning her degrees, Elise has made significant contributions to the research field as a Clinical Research Coordinator at Tufts Medical Center focusing on clinical trials for patients with PKD, as well as holding an epidemiology fellowship at the National Cancer Institute. Elise is excited to be able to contribute to patient-centered research in her position at the PKD Foundation.
Moderator
Tazin Aijaz, PharmD, BCPS
Nephrology Medical Science DirectorOtsuka Pharmaceutical Development & Commercialization, Inc.*
Tazin Aijaz, PharmD, BCPS, is a Nephrology Medical Science Director at Otsuka Pharmaceutical Development and Commercialization. She earned her Doctor of Pharmacy from the University of Cincinnati in Cincinnati, Ohio and then completed her clinical residency training at the Atlanta VA Medical Center with a focus in internal medicine and psychiatry. Prior to joining Otsuka, Dr Aijaz held various positions within the pharmaceutical industry in several therapeutic areas including immunology, movement disorders, and epilepsy.
*Elise Hoover is an unpaid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.
If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:
Registration
Related Resources
-
NephU Infographic – International IgA Nephropathy Prediction Tool (IIgAN-PT)
Infographic August 5, 2024Learn about the International IgA Nephropathy Prediction Tool (IIgAN-PT), the preferred prediction tool for time of kidney biopsy.
-
NephU Infographic – Kidney Disease Across The Lifespan
Infographic June 4, 2024Kidney disease affects people of all ages across the lifespan, impacting both patients and families. This infographic will dive into the statistics of kidney disease across the lifespan spectrum.
-
On-Demand Webinar: The Four-Hit Hypothesis & The Role Of APRIL In IgA Nephropathy
On-Demand Webinar May 21, 2024The goal of this on-demand webinar is to provide a detailed overview of the Four-Hit hypothesis as well as explain the role of APRIL in disease pathogenesis.
Related Events
-
Understanding the ADPKD Patient Journey: From Primary to Specialty Care
September 16 from 12:00 pm to 1:00 pm -
Women’s Health in Polycystic Kidney Disease (PKD) – A Focus on Pregnancy & Family Planning
September 30 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.